國立虎尾科技大學 |

Immunotherapy for Pediatric Malignancies

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Immunotherapy for Pediatric Malignancies/ edited by Juliet C. Gray, Aurélien Marabelle.
其他作者:	Gray, Juliet C.
面頁冊數:	IX, 297 p. 29 illus., 27 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Oncology . -
電子資源:	https://doi.org/10.1007/978-3-319-43486-5
ISBN:	9783319434865

Immunotherapy for Pediatric Malignancies
Immunotherapy for Pediatric Malignancies[electronic resource] /edited by Juliet C. Gray, Aurélien Marabelle. - 1st ed. 2018. - IX, 297 p. 29 illus., 27 illus. in color.online resource.

Introduction to Pediatric Cancer Immunotherapy -- Overcoming immune suppression in the tumor microenvironment: Implications for multi-modal therapy -- Allogeneic stem cell transplantation -- Overview of monoclonal antibody therapies -- Monoclonal Antibodies Targeting Hematological Malignancies -- Monoclonal Antibodies Directly Targeting Antigens on Solid Tumours -- Monoclonal antibodies targeting the immune system -- Adoptive T Cell Therapies for Children’s Cancers -- NK Cell and NKT Cell Immunotherapy -- Cancer Vaccines in Pediatrics -- Immune Adjuvants and Cytokine Therapies -- Immune biomarkers in pediatric malignancies -- Future perspectives.

This book provides a comprehensive overview of current immunotherapy strategies, and how these may be applicable to childhood cancers. The first part of the book reviews how the immune system recognizes cancer, and the various escape mechanisms allowing tumour growth. The importance of the tumor microenvironment and the challenges this may present to achieving effective immunotherapy are discussed. Monoclonal antibodies, cellular, cytokine and vaccine therapies are all comprehensively reviewed, with particular focus on their potential application to pediatric cancers. Practical aspects of delivering such therapies to children, likely toxicities and potential biomarkers are considered. Finally, consideration is given to how, in the longer term, such therapies may be combined with conventional therapies such as chemotherapy and radiotherapy. Edited by two distinguished pediatric oncologists with a collection of chapters from the most authoritative experts in cancer immunotherapy, this is an indispensable volume for pediatric oncologists and physicians working in childhood cancer care.

ISBN: 9783319434865

Standard No.: 10.1007/978-3-319-43486-5doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Immunotherapy for Pediatric Malignancies
LDR:03097nam a22003975i 4500 001 996575
003 DE-He213
005 20200705025101.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319434865 $9 978-3-319-43486-5
024 7 $a 10.1007/978-3-319-43486-5 $2 doi
035 $a 978-3-319-43486-5
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Immunotherapy for Pediatric Malignancies $h [electronic resource] / $c edited by Juliet C. Gray, Aurélien Marabelle.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a IX, 297 p. 29 illus., 27 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Introduction to Pediatric Cancer Immunotherapy -- Overcoming immune suppression in the tumor microenvironment: Implications for multi-modal therapy -- Allogeneic stem cell transplantation -- Overview of monoclonal antibody therapies -- Monoclonal Antibodies Targeting Hematological Malignancies -- Monoclonal Antibodies Directly Targeting Antigens on Solid Tumours -- Monoclonal antibodies targeting the immune system -- Adoptive T Cell Therapies for Children’s Cancers -- NK Cell and NKT Cell Immunotherapy -- Cancer Vaccines in Pediatrics -- Immune Adjuvants and Cytokine Therapies -- Immune biomarkers in pediatric malignancies -- Future perspectives.
520 $a This book provides a comprehensive overview of current immunotherapy strategies, and how these may be applicable to childhood cancers. The first part of the book reviews how the immune system recognizes cancer, and the various escape mechanisms allowing tumour growth. The importance of the tumor microenvironment and the challenges this may present to achieving effective immunotherapy are discussed. Monoclonal antibodies, cellular, cytokine and vaccine therapies are all comprehensively reviewed, with particular focus on their potential application to pediatric cancers. Practical aspects of delivering such therapies to children, likely toxicities and potential biomarkers are considered. Finally, consideration is given to how, in the longer term, such therapies may be combined with conventional therapies such as chemotherapy and radiotherapy. Edited by two distinguished pediatric oncologists with a collection of chapters from the most authoritative experts in cancer immunotherapy, this is an indispensable volume for pediatric oncologists and physicians working in childhood cancer care.
650 0 $a Oncology . $3 1253469
650 0 $a Pediatrics. $3 644839
650 0 $a Immunology. $3 592892
650 1 4 $a Oncology. $3 593951
700 1 $a Gray, Juliet C. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1287755
700 1 $a Marabelle, Aurélien. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1287756
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319434841
776 0 8 $i Printed edition: $z 9783319434858
776 0 8 $i Printed edition: $z 9783319828374
856 4 0 $u https://doi.org/10.1007/978-3-319-43486-5
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)